Liposomal targeting of angiogenic vasculature

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Angiogenic vasculature plays a critical role in various diseases, notably in promoting tumor growth.
• Targeting these specific blood vessels presents a viable therapeutic approach.
• Liposomes are versatile nanocarriers with potential for targeted drug delivery.

Purpose of the Study:

• To review recent progress in actively targeting liposomes to angiogenic endothelial cells.
• To highlight the potential of this strategy in disease treatment, particularly in oncology.

Main Methods:

• Literature review of studies employing targeted liposomes for angiogenic vasculature.
• Analysis of targeting strategies and their efficacy in preclinical and clinical settings.
• Discussion of challenges and future directions in liposome-based angiogenic targeting.

Main Results:

• Several strategies exist for actively targeting liposomes to angiogenic endothelial cells.
• Targeted liposomes have shown promise in inhibiting tumor growth and other angiogenic diseases.
• Advancements include novel targeting ligands and improved liposome formulations.

Conclusions:

• Active targeting of angiogenic vasculature with liposomes is a rapidly advancing field.
• This approach holds significant therapeutic potential for treating angiogenic diseases.
• Further research is needed to optimize delivery and clinical translation.